Clinical evaluation of low-molecular-weight heparin (FR-860) on disseminated intravascular coagulation (DIC) - a multicenter co-operative double-blind trial in comparison with heparin -
- 1 December 1993
- journal article
- clinical trial
- Published by Elsevier in Thrombosis Research
- Vol. 72 (6) , 475-500
- https://doi.org/10.1016/0049-3848(93)90109-2
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Hemorrhagic disease and thrombosis : advances in diagnosis and medical treatment.1.Fundamental matters for diagnosis.4.Fibrinolysis and factors related to inspection.Nihon Naika Gakkai Zasshi, 1991
- Marked potentiation of the plasminogenolytic activitiy of pro-urokinase by unfractionated heparin and a low molecular-weight heparinThrombosis Research, 1988
- Comparison of low molecular weight heparin to standard heparin in hemodialysis/hemofiltrationKidney International, 1988
- Lipolytic and anticoagulant activities of a low molecular weight fragment of heparinEuropean Journal of Clinical Investigation, 1985
- Anwendung von niedermolekularem Heparin bei HämodialysepatientenJournal of Molecular Medicine, 1985
- Heparin and a low molecular weight fraction enhances thrombolysis and by this pathway exercises a protective effect against thrombosisThrombosis Research, 1983
- Anticoagulant activities and effects on platelets of a heparin fragment with high affinity for antithrombinThrombosis Research, 1980
- Effect of Heparin and Heparin Fractions on Platelet AggregationJournal of Clinical Investigation, 1980
- Severe, acute disseminated intravascular coagulationThe American Journal of Medicine, 1979
- HEPARIN-INDUCED DECREASE IN CIRCULATING ANTITHROMBIN-IIIThe Lancet, 1977